Senior World – Online community for seniors across America

January 4, 2010

Over A Quarter Of Brits Are Not Taking Their Medicines Correctly

Filed under: Pharmacy — Senior Helping Senior @ 4:01 pm

Many people stock up on medicines in the run up to Christmas and New Year. A survey* conducted by the National Pharmacy Association (NPA) has discovered that 29% of people in the United Kingdom, over the age of 50, admit they forget to take their prescribed medicine. While 22% stop taking their medicine before the end of the course if they feel better.

People who take prescribed medicines may take less than half the prescribed dose. Some forget, some misunderstand the instructions, and some refuse to believe they need medicines treatment at all.

John Turk, NPA Chief Executive said: “The statistics are not surprising as it is not always possible for GPs to enter into extended explanations about particular treatments, and even if they do patients may not remember or take in all the information provided.”

“Most people associate their local pharmacy with the dispensing of prescriptions and see it as a place where they can also buy medicines over the counter. However, pharmacists should be seen as the first port of call for healthcare advice and the best source of advice on medicines. No other health professional is as highly trained in medicines and their use as a pharmacist.”

The Medicines Use Review service at community pharmacies in England and Wales is a free service that helps improve people’s understanding and makes sure people get the most out of their medicines. The Medicines Use Review consultation is held in an area where the patient and the pharmacist can have a private discussion.

The NPA is keen to encourage people to make more use of clinical services available from community pharmacy. Despite the fact that pharmacists have five years’ training and are highly accessible many people are still unaware that they can discuss any aspect of their medicine related care with their pharmacist.

December 22, 2009

Nearly 60 Million Went Without Health Coverage In Recent Year

Filed under: Health News — Senior Helping Senior @ 10:33 pm

How many people in this country are without insurance? About 60 million during all or part of a recent year, according to anestimate just out from the Centers for Disease Control and Prevention.

From interviews by the Census Bureau, the CDC figures 45.4 million people, or 15.1% of the U.S. population of all ages didn’t have any health insurance when the question was posed during the first half of 2009. But widen the question ask if people didn’t have coverage for any part of the past year and you get to 58.4 million people, or 19.4 percent of the population.

To us, the real interesting stuff emerges in the group of folks aged 18 to 64, generally without recourse to Medicare or to SCHIP coverage for kids.

In that group, about 1 in 4 people didn’t have health coverage for at least part of the year. That figure, lower than the 1 in 5 who were uninsured at the time the questions were asked, illustrates how commonplace it is for people to slip in and out of coverage.

For the broader health overhaul debate, it’s another reminder of how vulnerable people in their working years are to losing insurance. Indeed, 60.6 percent of the unemployed 15- to 64-year-olds had been without coverage for at least part of the past year.

And each lapse also raises the possibility of a coverage denial when a person tries to get insured again.

Senators Who Voted Against Drug Imports Got More Big Pharma Money

Filed under: Health News, Pharmacy — Senior Helping Senior @ 10:30 pm

Nobody on Capitol Hill takes kindly to a spreadsheet that lines up their campaign contributions with their floor votes. But that’s what Maplight.org, a nonprofit database operation, has just done, producing a mashup with the tally from the Senate’s vote Monday on drug importation and 6 1/2 years of campaign finance data.

How The Big Recipients Of Drugmakers’ Contributions Voted On Drug Importation

Senator Party Pharma money Vote
Max Baucus, MT D $261,020 No
Richard Burr, NC R 301,898 No
Orrin Hatch, UT R 262,950 No
Joe Lieberman, CT I 199,540 No
Mitch McConnell, KY R 225,900 Yes
Arlen Specter, PA D 353,550 Yes
Source: Maplight.org

Importation is illegal. Advocates of legalizing it say that American consumers would save $100 billion over 10 years, as competition would force prices down for prescription drugs. The pharmaceutical industry and the Food and Drug Administration say drug safety would be jeopardized. When importation was proposed as an amendment to health care overhaul, the Senate rejected it — 51 for importation and 48 against, with 60 needed to approve.

And if you look at the Maplight analysis, you’ll find–little surprise here–that senators voting nay have averaged 66 percent more in campaign contributions from Big Pharma than senators who voted yea. The difference: $85,812 vs. $51,803, spread over the period Jan. 1, 2003, to Aug. 12, 2009. Not a lot of dollars if you prorate it, but it is consistent.

Maplight earlier ran the numbers on a couple other pharma-related votes–a Senate Finance Committee vote on Medicare drug prices three months ago and, in a less refined analysis, a 2007 Senate vote on an earlier prescription drug bill.

Political scientists have devoted years to debating the potential links between votes and money. The predominant wisdom: money doesn’t move votes, it follows them. Donors tend to give to lawmakers who already are on their side.

The Maplight data don’t settle that debate. What they do point out, however, is the enduring relationships between lawmakers and interest groups, and the monetary cement that helps them bond.

December 16, 2009

Prescription Drug Import Amendment Divides Senate Democrats

Filed under: Pharmacy — Senior Helping Senior @ 2:42 pm

The Senate is battling over a proposed amendment that would allow prescription drugs to be imported from other countries where prices are lower.

“Drugmakers intensified their lobbying push Monday against a popular proposal to allow Americans to buy cheaper drugs from other countries, one of several heated disputes that have bogged down negotiations over a heath-care reform bill,”The Washington Post reports. The dispute complicated Senate Democrats’ efforts to rally 60 pass health reform legislation before Christmas and also “poses a particularly difficult political challenge for President Obama, who co-sponsored a similar bill when he was in Congress and who included funding for the idea in his first budget.”

“The amendment, sponsored by Sen. Byron L. Dorgan (D-N.D.), would allow pharmacies and wholesalers to import U.S.-approved medication from Canada, Europe, Australia, New Zealand and Japan, where drug costs are far lower because of price controls. The measure has attracted bipartisan support from lawmakers, including Sens. Olympia J. Snowe (R-Maine) and John McCain (R-Ariz.).” The pharmaceutical industry, however, “has responded with a fierce lobbying campaign aimed at killing the proposal, focusing on Democratic senators from states with large drug and research sectors.” (Eggen, 12/15).

NPR: “The Congressional Budget Office has estimated there could be more than $100 billion in savings to U.S. prescription drug buyers over the next decade – $20 billion of which would be for the federal government – if cheaper prescription drugs from abroad were allowed to compete in the U.S. market. But opponents question the safety of the drugs. Food and Drug Administration Commissioner Margaret Hamburg wrote several senators saying she commends the efforts Dorgan has made to reduce risks associated with importing prescription drugs. Still, she concluded his measure has too many unresolved safety issues” (Welna, 12/14).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

December 15, 2009

Drug Importation Takes Center Stage On Senate Floor

Filed under: Health News, Money Saver, Pharmacy — Senior Helping Senior @ 9:51 pm

Debate on a proposal that would make it easier to bring prescription drugs into the country from abroad is taking center stage on the Senate floor as part of the health care reform debate.

The Associated Press: “A bipartisan group of lawmakers hopes to finally win a long struggle to ease curbs against importing low-cost prescription drugs but will have to overcome the Obama administration and the pharmaceutical industry to do so.” The amendment would “allow U.S. pharmacies and drug wholesalers to import Food and Drug Administration-approved drugs from Canada, Europe and a few other countries. People on both sides of the issue say it will be tough for supporters to get the 60 votes they’ll need to win” (Fram, 12/10).

The Seattle Times/The Associated Press: “Some import supporters question whether the administration is acting to keep the powerful pharmaceutical industry’s support for [President Barack] Obama’s effort to overhaul the nation’s health-care system. An administration official denied that. … Even before Dorgan introduced it Tuesday night, the Food and Drug Administration (FDA) sent senators a letter saying the plan would be ‘logistically challenging’ to implement and raises ’significant safety concerns.’ … Dorgan said he was surprised by the letter because Obama co-sponsored Dorgan’s proposal in 2007 as a freshman Democratic senator from Illinois. In addition, Dorgan noted, White House Chief of Staff Rahm Emanuel sponsored another version of the bill that same year as a Democratic House member from Illinois” (Fram, 12/10).

The Wall Street Journal: “In a letter to Republican Sen. Sam Brownback of Kansas, FDA Commissioner Margaret Hamburg also said overseeing importation would be ‘resource intensive.’ The letter was a response to a request by Sen. Brownback, who in the past has opposed reimportation of drugs.” Dorgan responded by calling the FDA letter “completely bogus” (Mundy, 12/9).

Bloomberg reports that drugmakers are speaking out against a proposal to allow reimportation of cheaper prescription drugs from Canada. “The plan, from lawmakers led by (senators) North Dakota Democrat Byron Dorgan and Maine Republican Olympia Snowe, drew fire from drugmakers such as Indianapolis-based Eli Lilly & Co.”

“‘It would be a huge mistake for Congress to pursue policies that could expose Americans to counterfeit and substandard drug products,’ said Ken Johnson, senior vice president of the Pharmaceutical Research and Manufacturers of America, the Washington industry association” (Gaouette and Jensen, 12/10).

CQ HealthBeat also reports on the FDA letter: “It was unclear when the Senate might vote on the amendment offered by Byron L. Dorgan, D-N.D. … John McCain, R-Ariz., said the deal with the pharmaceutical industry was the real reason behind the FDA letter. He mocked the agency’s reasoning in the letter. … [Meanwhile], Hamburg ended the letter by promising to work with senators to explore other options for drug importation (Ethridge, 12/9).

See related news on Wednesday’s Senate negotiations and debate on drug re-importation at Kaiser Health News.

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

Prescription Drug Costs Double Over A Decade

Filed under: Money Saver, Pharmacy — Senior Helping Senior @ 9:36 pm

The feds just put out a neat little summary of what’s happened with health care spending for young and middle-aged people in recent years.

Guess what? It’s up. The health tab for 18- to 44-year-olds hit $231 billion in 2006, up $40 billion from $191 billion in 1996. On average, each person spent $2,703 on health care in 2006, up 24 percent from $2,177 spent a decade earlier. (All the figures were converted to 2006 dollars to adjust for inflation.)

OK, you expected that, we’d imagine. But take a look at some of the specific ways it’s gone up.

Spending on prescription drugs jumps right out, with the share of health money going to medicines at 18 percent in 2006, up from 10 percent the decade before. One big reason: the average cost of the drugs doubled to $161 per purchase from $79 in 1996.

ER costs were another big mover. An emergency visit to the hospital that cost $393 in 1996 increased 62% to $638 in 2006.

But the data weren’t all bad. The average charge for a day in the hospital barely budged, up about 6 percent to $2,430 in 2006 from $2,336 in 1996.

In case you were wondering, private insurance paid the bills for more than half the care, with about one-fifth coming out of consumers’ pockets, the researchers from the Agency for Healthcare Research and Quality said. Medicaid paid most of the rest.

Nielsen: More seniors becoming Web regulars

Filed under: Senior Citizens — Senior Helping Senior @ 9:34 pm

Although those aged 65 and older make up less than 10 percent of active Web users, a new Nielsen study has found that over the past five years, the number of seniors using the Internet regularly has increased by a 55 percent.
According to Nielsen, there were just 11.3 million seniors actively using the Web in November 2004. Five years, later, there are now more than 17.5 million seniors surfing around. Senior women have picked up the Web faster than men, outpacing men by 6 percent.

Seniors aren’t just going to the Web, they’re staying there. Nielsen found that the amount time seniors surf increased 11 percent in the last five years from 52 hours per month to a little more than 58 hours per month in November.
Nielsen research director Chuck Schilling said in a statement that seniors are sharing photos, social networking, and reading the news.
According to the data Nielsen culled from its study, 88.6 percent of seniors use the Web to check their personal e-mail. The study also found that 68.6 percent of respondents were viewing and printing maps online, while 60.1 percent said that they check the weather.
Nielsen said the top online destination for seniors in November was Google Search, tallying 10.3 million unique visitors. Windows Media Player was used by 8.2 million unique senior visitors, and Facebook captured the third spot with 7.9 million visitors.
Facebook is where the most growth among seniors was seen. A year ago, Facebook was ranked 45th for the most popular senior destination–a far cry from its current third spot. That kind of growth falls in line with the dramatic increase in senior use of social networks and blogs. Nielsen said those 65 and older have increased social and blog visiting by 53 percent. They now represent 8.2 percent of all social network and blog visitors on the Web.

Canadian Internet Pharmacy. Latest stumbling block in Health Care.

Filed under: Pharmacy — Senior Helping Senior @ 9:32 pm

The latest stumbling block for an overhaul of health care lies north of the border.

The Senate, already poking along, put the whole thing on hold yesterday amid growing support for a measure that would allow American pharmacies and drug wholesalers to import cheaper versions of drugs already approved by the Food and Drug Administration.

For years many Americans in northern states have headed to Canada for cheaper medicines. Then Internet purveyors, many shady, offered cut-rate prices on brand-name drugs supposedly from Canada or other countries with quality standards on par with those of the FDA.

Early in the week, FDA Commissioner Margaret Hamburg said in a letter to senators that the idea was “logistically challenging” to implement and raised safety concerns, mainly over counterfeits.

Democratic Sen. Byron Dorgan of North Dakota, chief sponsor of the importation amendment, called the FDA’s complaints “completely bogus.” He’s been a booster of the approach for years.

But the administration and some Senate Democrats are hanging tough in an apparent nod to drugmakers’ interests. “People are walking on eggshells,” Dorgan said yesterday, according to the New York Times. “If we pass legislation allowing people freedom to import drugs, the pharmaceutical industry might not support the health care bill.”

December 8, 2009

Cost of diabetes could hit $17B a year by 2020 in Canada

Filed under: Health News, Pharmacy — Senior Helping Senior @ 3:56 pm

The rising rates of diabetes in Canada could cost the economy as much as $17 billion by the year 2020, according to a new report that calls on the federal government to do more to ease the economic burden.

The Canadian Diabetes Association’s report, An Economic Tsunami: The Cost of Diabetes in Canada, warns that more than 20 people are diagnosed with the disease every hour of every day, and that number is expected to continue to rise over the coming years.

“Many of us will be affected, and the numbers show that by 2020 one in 10 Canadians will have diabetes,” said Ellen Malcolmson, president and CEO of the Canadian Diabetes Association.

Using data from the Canadian National Diabetes Surveillance System and the Economic Burden of Illness report, a mathematical model was developed to determine the prevalence of diabetes now and in the future, and, the associated economic costs. Malcolmson said it’s an important tool to provide accurate Canadian statistics instead of extrapolating from U.S. data.

It is estimated that 2.5 million Canadians have diabetes and that in the next decade 3.7 million more Canadians will be diagnosed with it.

The report also notes that an estimated 700,000 people have diabetes and don’t know it.

Rising obesity rates, an aging population and changes in the ethnic mix of new immigrants are all believed to be driving the increasing rates of diabetes. Almost 80 per cent of new Canadians are from populations that are at a higher risk for diabetes, including people of South Asian, Asian, African and Hispanic descent.

The economic burden of diabetes is calculated to be about $12.2 billion next year, and the cost is expected to rise by another $4.7 billion by 2020. The direct financial burden on the health-care system includes the cost of hospitalizations, visits to general physicians and specialists, and medication. Indirect costs were calculated to include the loss of economic output due to illness, long-term disability or premature death.

“The cost is so significant when you think about it from a health-system perspective,” said Malcolmson.

The price tag for hospitalizations and visits to doctors is expected to rise the fastest over the next 10 years and will “severely tax” the health-care system, the report said.

The model shows that visits to general physicians will rise to more than 14 million by 2020, visits to specialists to 9.1 million and the number of amputations performed every year due to diabetes is expected to go up to 630,000 by 2020.

The Canadian Diabetes Association is calling on the federal government to renew the Canadian Diabetes Strategy and the Aboriginal Diabetes Initiative, which expire in 2010. Aboriginal Canadians are three to five times more likely to develop Type 2 diabetes than non-aboriginal Canadians.

The national strategy was renewed in the 2005 budget and $90 million spread over five years was committed to it and $190 million was directed to the aboriginal diabetes initiative.

“It’s important to us that the strategies are renewed and enhanced,” said Malcolmson. Her association is also looking for the federal government to increase the tax credits and deductions that are allowed for medical expenses, and the provinces will also be asked to help, she said.

People with diabetes often have to pay for medications and supplies, such as glucose testing strips, out of their own pocket and some who can’t afford the expenses then don’t manage their disease well, which leads to problems later, said Malcolmson.

December 2, 2009

Seniors Often Reluctant To Switch Medicare Drug Plans

Filed under: Money Saver, Pharmacy — Senior Helping Senior @ 5:26 pm

Seniors have until the end of the year to switch Medicare drug plans to get a better deal. But many will pass up the chance to save hundreds of dollars a year in prescription costs.

The reason: With dozens of drug plans on the market, many seniors get overwhelmed at the prospect of changing plans, even if a different one would better suit their needs and lower their costs. But with the average premium for a Medicare drug plan increasing 11 percent in 2010, consumer advocates say seniors have even more reason to check out the options and consider their costs.

Robert Lowenstein, a 91-year-old retired Washington attorney, chose a UnitedHealthcare-AARP drug plan in 2006, when the stand-alone policies first became available. He trusted AARP, which was UnitedHealthcare’s marketing partner, and has stuck with the policy because he figured changing would be confusing and time-consuming. But a look at the “Prescription Drug Plan Finder” on Medicare’s Web site indicates that Lowenstein would save about $400 a year by selecting a different UnitedHealthcare plan or a policy offered by CVS Caremark. Similarly, his wife, Elizabeth, 82, would save $450 a year by switching from her UnitedHealthcare plan, reducing their drug costs by more than 20 percent.

Only an average of 7 percent of the 17 million seniors on Medicare drug plans switch plans each year, according to the Centers for Medicare and Medicaid Services, the federal agency that runs Medicare. Experts on Medicare say this suggests that millions of beneficiaries could be paying more than they should for their drug coverage.

Molly Schuchat, 81, a District resident who has been with the same Blue Cross and Blue Shield drug plan since 2006, said, “I know I could probably do better, but it’s what I’m used to, and it’s a hassle to change.” Yet, according to the Medicare Web site, Schuchat could save as much as $744, about 20 percent of her costs, by changing plans next year.

The Medicare drug benefit was created by Congress in 2003 to help those seniors — one in four at the time — who didn’t have prescription-drug coverage. Rather than giving all seniors the same coverage, Congress decided to have private companies offer the benefit through competing plans. As a result, insurers offer different levels of coverage for different drugs. Some experts say the competition has held down costs, but some seniors — and their children — say the wide array of plans can be daunting, making it unnerving or too perplexing to change.

Dozens Of Choices

The open season for selecting or changing plans began Nov. 15 and ends Dec. 31. The number of Medicare drug plans varies from state to state, from a low of 39 in Alaska to 53 in Pennsylvania and West Virginia. In the District, there are 45 drug plans, with monthly premiums ranging from $11.60 to $99.90. Maryland seniors can choose from 45 plans with premiums from $11.60 to $120.20. In Virginia, there are 44 plans with premiums from $16.30 to $97.90.

Medicare’s easy-to-use “plan finder” allows seniors to plug in their medications and see which plan would have the lowest overall annual costs. But many seniors are uncomfortable going online or unable to use computers to sort through the different policies. Last year, only 688,000 seniors, or 2.5 percent, went online to enroll in Medicare drug or health plans. The rest did it the old-fashioned way: by telephone or letter.

To help seniors choose a plan, Howard Houghton, a coordinator at the Virginia Insurance Counseling and Assistance Program in Fairfax, visits senior centers and retirement communities with his laptop computer. Many seniors, he said, think that once they join a drug plan, they should stick with it for the rest of their lives. He said that’s partly because they generally stayed with the same private health insurance plan for many years before enrolling in Medicare.

“But with these drug plans, you really do have to do your homework each year,” he said. Some seniors, he added, have begun to reconsider their options in response to the latest premium increases and the faltering economy, but many have not.

Federal officials wonder why even more Medicare beneficiaries aren’t switching. “We do see some degree of hesitation from our beneficiaries to change plans or go to the best optimal plan,” said Jonathan Blum, acting director of the CMS Center for Drug and Health Plan Choice. This year, the agency is doing more to reach out to seniors directly, including sending letters to the 6.5 million low-income seniors across the nation who are eligible for reduced rates to make sure they are in drug plans that don’t charge a monthly premium.

Lydia Baker, a coordinator of the federally funded State Health Insurance Counseling and Assistance Program in Tucson, Ariz., said many seniors choose a plan initially because they recognize the name of the company or are attracted by low premiums.

Baker, who is on Medicare herself, said many seniors find the prospect of changing plans frightening. “If they found something and think it’s working they don’t want to move,” she said.

The price for such inaction will get higher next year as the average monthly premium for a Medicare drug plan rises to $38.85 a month. That’s 50 percent more than seniors paid in 2006.

The average premium for the most popular drug plan — UnitedHealthcare’s AARP Medicare RX Preferred, which has nearly 3 million customers — has jumped 50 percent to $39.39 in 2010 from $26.31 in 2006, according to the Kaiser Family Foundation. (Kaiser Health News is a part of the foundation.) The average premium for Humana’s PDP Enhanced, the second most popular plan with 1.6 million customers — will be $41.53 next year, 182 percent higher than in 2006. The actual premiums vary by state.

For some seniors, these premium increases will be unavoidable. But others could save substantial amounts of money by checking out a variety of plans.

Geoffrey Joyce, a senior economist at the Rand Corp., a nonprofit think tank based in Santa Monica, Calif., said health plans benefit from seniors’ fear of changing plans. “If they feel like they have them locked in, they can raise prices and get away with it,” he said. Humana officials say it is inaccurate to suggest that they initially offered artificially low prices on their plans in a bid to grab market share. They say they have had to raise prices to reflect the increased costs of providing the coverage.

The large health insurers that sell drug plans say that seniors don’t switch plans because they’re satisfied with their coverage. “Many [Medicare] Part D members are extremely or very satisfied with the Medicare prescription plan in which they’re currently enrolled,” said Jonathan Stone, a spokesman for Minnetonka, Minn.-based UnitedHealthcare. The company, the nation’s largest private health insurer, has the largest number of Medicare drug members, about 4.3 million seniors, or about 25 percent of the market.

Some smaller health insurers say it’s difficult trying to persuade seniors to switch from more-established and well-known plans such as UnitedHealthcare, Blue Cross and Blue Shield and Humana. “It’s very challenging because I don’t think most seniors are really shopping plans,” said Jaydip Dattaray, chief operating officer at New York-based Fox Insurance Co., which has about 85,000 Medicare drug plan members.

Beyond Premiums

In figuring out their prospective drug costs, seniors need to look beyond premiums and also consider deductibles and co-payments, which can vary by drug. In addition, they also have to consider whether they want to pay more in premiums to have some coverage in the Medicare program’s coverage gap, commonly called the “doughnut hole.” In 2010, this lapse in coverage will begin after an enrollee incurs $2,830 in total drug spending and end when an enrollee has spent a total of $4,550 out of pocket. After that, beneficiaries are responsible for just 5 percent of their drug costs.

The Democrats’ health-care overhaul bills in the House and the Senate could have a major impact on the Medicare prescription-drug program. The House bill would close the gap in coverage by 2019, although the Senate bill wouldn’t. Under both bills, starting in 2010, beneficiaries would be able to buy brand-name drugs for half price once they’re in the coverage gap. The annual enrollment period would also be moved up a month to start in mid-October.

Meanwhile, the Lowensteins are considering changing plans. “I definitely think Robert should change plans and so should I,” said Elizabeth Lowenstein.

This story was produced through collaboration between NPR and Kaiser Health News (KHN), an editorially independent program of the Henry J. Kaiser Family Foundation, a nonpartisan health-care policy research organization. The Kaiser Family Foundation is not affiliated with Kaiser Permanente.

Next Page »

Blog at WordPress.com.